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Objectives. The purpose of this investigation was to differentiate
chronic pulmonary thromboembolism (CPTE) from primary pul-
monary hypertension (PPH) by using noninvasive Doppler ultra-
sound techniques.
Background. A recent investigation in our laboratory has
indicated that the pulmonary artery (PA) pressure waveform
conveys significant information that can be used to differentiate
CPTE from PPH. Pulse pressure was markedly larger in CPTE
than in PPH, indicating that the major occlusive site is central in
CPTE and peripheral in PPH.
Methods. In 19 patients with CPTE and 16 patients with PPH,
we estimated PA systolic pressure and diastolic pressure from the
velocities of tricuspid regurgitation and pulmonary regurgitation,
respectively.
Results. Estimated systolic pressure was not significantly dif-
ferent between CPTE and PPH (mean [6SD] 81 6 20 and 79 6
21 mm Hg, respectively, p 5 NS). Pulse pressure normalized by
systolic pressure was higher in CPTE than in PPH (0.82 6 0.05 vs.
0.63 6 0.10, respectively, p < 0.01). Pulse pressure normalized by
mean pressure was also higher in CPTE than in PPH (1.65 6 0.30
vs. 0.94 6 0.25, respectively, p < 0.01). Receiver operating
characteristic analysis indicated that pulse pressure normalized
by systolic pressure separated CPTE from PPH, with a sensitivity
of 0.95 and a specificity of 1.00. Pulse pressure normalized by
mean pressure also separated them, with a sensitivity of 0.95 and
a specificity of 1.00.
Conclusions. Normalized pulse pressures estimated from Dopp-
ler ultrasound measurements enable us to noninvasively differen-
tiate between CPTE and PPH.
(J Am Coll Cardiol 1998;31:1367–71)
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A recent investigation in our laboratory (1) has indicated that
the pulmonary artery (PA) pressure waveform conveys signif-
icant information that can be used to differentiate chronic
pulmonary thromboembolism (CPTE) from primary pulmo-
nary hypertension (PPH). The key to differentiating between
the two diseases is the relative magnitude of pulse pressure to
mean pressure. The pulse pressure was markedly larger in
CPTE than in PPH, indicating that the major occlusive site is
central in CPTE and peripheral in PPH. Because PA pressure
may be noninvasively estimated by using Doppler echocardi-
ography from the regurgitant flow of the pulmonary and
tricuspid valves (2,3), it is conceivable that the pulsatility of the
PA pressure waveform may be identified from those noninva-
sively obtained data. The purposes of this investigation were to
derive indexes of pulsatility of PA pressure using Doppler
echocardiography and to examine their significance in diagnos-
ing CPTE and PPH.
We approximated PA systolic pressure by measuring regur-
gitant flow across the tricuspid valve, using a modified Ber-
noulli equation (4). We also approximated diastolic pressure
by measuring regurgitant flow across the pulmonary valve. The
results indicated that, despite such approximations of PA
systolic and diastolic pressures, estimated pulsatility was mark-
edly more increased in CPTE than in PPH, suggesting the
usefulness of the proposed noninvasive technique in differen-
tiating CPTE from PPH.
Methods
Study subjects. This was a retrospective, unblinded study.
Between 1988 and 1996, 61 patients were admitted to the
National Cardiovascular Center, Suita, Japan, for evaluation of
symptomatic pulmonary hypertension (New York Heart Asso-
ciation functional class II through IV) with no known causes
other than CPTE and PPH. Of these, 26 patients were
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excluded either because peak PA pressure estimated by tricus-
pid regurgitation (TR) did not exceed 50 mm Hg or because
the recording of pulmonary regurgitant (PR) jet was unavail-
able. We did not routinely record PR flow. No patients were
excluded because of poor quality Doppler measurements.
Pulmonary hypertension might be more severe in the PPH
group, because right atrial (RA) pressure was slightly higher
(9.5 vs. 6.1 mm Hg). Clinical diagnoses for these patients were
based on the following criteria: CPTE was diagnosed when
pulmonary arteriography revealed opacification of filling de-
fects and when areas of ventilation-perfusion mismatch typical
of regionally impaired pulmonary perfusion were identified by
standard radioisotope imaging. No history of acute episodes of
chest pain or dyspnea, or both, was required for the diagnosis.
The diagnosis of PPH was made after echocardiography,
cardiac catheterization and arteriography; ventilation-
perfusion scanning and pulmonary function testing assisted in
excluding other known causes of pulmonary hypertension. We
excluded from the PPH group patients with signs of collagen
vascular disease, positive antinuclear antibody, history of drug
abuse, use of diet pills or history of liver disease. There were 19
patients with CPTE (11 men and 8 women, age 28 to 64 years
[mean 6 SD 55 6 14]) and 16 patients with PPH (5 men and
11 women, age 19 to 61 years [mean 6 SD 37 6 15]). This
resulted in a larger proportion of female (p , 0.05) and
younger (p , 0.01) patients in the PPH group, as reported (5).
All patients in both groups had normal sinus rhythm. The
protocol was in accordance with Institutional Guidelines for
Human Research, and each patient gave written, informed
consent for the diagnostic procedures required by Doppler
ultrasound measurement, which stated that the results of the
examination can be used for the retrospective study.
Doppler examination. Differences between CPTE and
PPH, in terms of dynamic-mechanical properties of the PA
system, would be more evident in the pressure waveform than
in the mean pressure, granted that the mean pressure reflects
the level of total arterial resistance (1). Thus, we focused on
the systolic, diastolic and pulse pressure values. We approxi-
mated these values by means of Doppler ultrasound measure-
ments, with some variability in measurements.
We recorded Doppler flow velocities of both TR and PR to
estimate PA systolic and diastolic pressure, respectively. Re-
gurgitant flow was quantified using a continuous wave Doppler
method with a 2.5-MHz transducer (Toshiba, model 160A,
Tokyo). We chose this method because the regurgitant flow
velocity could cause aliasing with pulsed-wave Doppler mea-
surements in these patients. Each patient was examined in the
supine position by trained clinicians who had no knowledge of
the clinical diagnosis. Guided by color-encoded Doppler flow
mapping, the continuous wave Doppler beam was orientated
as parallel as possible to the direction of the TR and PR jets.
Then, minor manipulations of the transducer were performed
to obtain the highest velocity. Using a modified Bernoulli
equation (4), we approximated peak systolic pressure from the
measured peak TR velocity on the assumption that RA
pressure was zero. We also approximated diastolic pressure
from the velocity of PR flow at the moment of its abrupt
deceleration in late diastole, on the assumption that right
ventricular (RV) diastolic pressure was zero. If abrupt decel-
eration was not obvious, we approximated it from PR flow at
the moment of the R wave. Because the absolute pressure
value varied depending on the severity of disease, we normal-
ized pulse pressure by either peak pressure or mean pressure
in establishing indexes for differentiating CPTE from PPH. We
obtained mean pressure by adding one-third of the value of
pulse pressure to the estimated diastolic pressure.
Statistical analysis. Pooled data are expressed as the mean
value 6 SD. Differences between the two groups were com-
pared by using the unpaired t test. A p value , 0.05 was
considered significant. Performance of each index in differen-
tiating between CPTE and PPH was assessed with receiver
operating characteristic (ROC) curve analysis (6). In this
report, sensitivity stands for the ratio of the number of patients
correctly diagnosed as having CPTE to the total number of
patients with CPTE. Specificity stands for the ratio of the
number of patients correctly diagnosed as having PPH to the
total number of patients with PPH. We calculated the combi-
nations of sensitivity and specificity for cutoff values at the
midpoints of the ranges between adjacent pulsatility index
values.
Results
Shown in Figure 1 are the scheme of PA and RV pressure
waves (central panels) and representative recordings of TR
(right panels) and PR (left panels) measured by continuous
wave Doppler methods. The flow velocities of PR at end-
diastole are lower in CPTE (top, left panel) than in PPH
(bottom, left panel), even if those recordings of TR are
comparable.
Basic PA hemodynamic variables are summarized in Table
1. There were no significant differences in heart rate or PA
systolic pressure between patients with CPTE and those with
PPH. In contrast, diastolic and mean pressure were signifi-
cantly higher in the PPH group than in the CPTE group. This
resulted in a higher pulse pressure in CPTE than in PPH.
Shown in Figure 2 are normalized pulse pressure values in
patients with CPTE and those with PPH. Pulse pressure
normalized by systolic pressure was significantly higher in the
CPTE group than in the PPH group (0.82 6 0.05 vs. 0.63 6
Abbreviations and Acronyms
CPTE 5 chronic pulmonary thromboembolism
PA 5 pulmonary artery
PPH 5 primary pulmonary hypertension
PR 5 pulmonary regurgitation/regurgitant
RA 5 right atrium/atrial
ROC 5 receiver operating characteristic
RV 5 right ventricle/ventricular
TR 5 tricuspid regurgitation/regurgitant
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0.10, p , 0.01) (Fig. 2A), with a few overlap cases. Pulse
pressure normalized by mean pressure was also significantly
higher in the CPTE group than in the PPH group (1.65 6 0.30
vs. 0.94 6 0.25, p , 0.01) (Fig. 2B).
We evaluated the sensitivity and specificity of normalized
pulse pressure in differentiating CPTE from PPH. ROC curves
of these indexes are shown in Figure 3. Pulse pressure normal-
ized by systolic pressure separated CPTE from PPH reason-
ably well, with a sensitivity of 0.95 and a specificity of 1.00 at
the cutoff value of 0.77 (Fig. 3A). Similarly, pulse pressure
normalized by mean pressure separated CPTE from PPH
reasonably well, with a sensitivity of 0.95 and a specificity of
1.00 at the cutoff value of 1.35 (Fig. 3B).
Discussion
We demonstrated in this study that CPTE could be differ-
entiated from PPH on the basis of PA pressure pulsatility
Figure 1. Continuous Doppler measurements in representative cases
with the scheme of PA and RV pressure waveforms (center). The top
panels are from a patient with CPTE. The bottom panels are from a
patient with PPH. The right panels are the continuous Doppler
measurements of TR. The left panels are the continuous Doppler
measurements of PR. Although the Doppler flow velocities of TR are
comparable between CPTE and PPH, those of PR are lower in CPTE
than in PPH. The peak pressure gradient (TR) across the tricuspid
valve during systole is defined as a measure of PA systolic pressure. We
also approximated diastolic pressure (PR) from the velocity of PR flow
at the moment of its abrupt deceleration in late diastole. If the abrupt
deceleration was not identifiable, we approximated it from PR flow at
the moment of the R wave.
Table 1. Heart Rate and Pulmonary Artery Hemodynamic Variables
in Patients With Chronic Pulmonary Thromboembolism and Primary
Pulmonary Hypertension
CPTE
Group
PPH
Group p Value
Heart rate (beats/min) 79 6 15 81 6 11 NS
Pulmonary artery pressure (mm Hg)
Systolic 81 6 20 79 6 15 NS
Diastolic 14 6 5 27 6 3 , 0.01
Mean 41 6 10 54 6 9 , 0.01
Pulse 67 6 18 52 6 21 , 0.05
Pulmonary artery pressure values were estimated by continuous Doppler
ultrasound measurements. CPTE 5 chronic pulmonary thromboembolism;
PPH 5 primary pulmonary hypertension.
Figure 2. Normalized pulse pressure obtained by two methods. Esti-
mated pulse pressure was normalized by either systolic pressure (A) or
mean pressure (B). Both indexes differentiated CPTE from PPH
reasonably well, with minimal overlap. Solid circles 5 individual data;
open circles 5 mean values; bars 5 SD.
Figure 3. ROC curve of normalized pulse pressure indexes in differ-
entiating CPTE from PPH. Pulse pressure normalized by systolic
pressure separated CPTE from PPH with a sensitivity of 0.95 and a
specificity of 1.00 at the cutoff value of 0.77 (A). Pulse pressure
normalized by mean pressure separated CPTE from PPH with a
sensitivity of 0.95 and a specificity of 1.00 at the cutoff value of 1.35 (B).
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estimated with Doppler ultrasound measurements. This
method is completely noninvasive and can be applied to
virtually all patients with pulmonary hypertension. In current
practice, because the results of ventilation-perfusion radioiso-
tope scanning might be unsatisfactory for establishing an
accurate differential diagnosis in some patients (7), the use of
pulmonary arteriography has been necessary at the expense of
possibly serious and sometimes fatal complications (8). The
clear separation between patients with CPTE and those with
PPH in this study, with a relatively small sample size, indicates,
if proven true in a larger group, that Doppler ultrasound
measurement would be an additional diagnostic tool in differ-
entiating between CPTE and PPH.
Mechanistic consideration. In CPTE, thrombi are lodged
in the proximal arteries and result in stenosis of large arteries
and possibly in stiffening of the arterial wall (9). Narrowing of
the arterial segments increases resistance of the segments, and
stiffening of the arterial segments increases characteristic
impedance of the segments. Both changes increase apparent
proximal arterial resistance (10). Pulmonary peripheral resis-
tance is relatively normal. Thus, the ratio of proximal resis-
tance (characteristic impedance) to peripheral resistance in-
creases in CPTE, which would make pulse pressure large
relative to mean pressure. Indeed, various investigators have
shown, in the systemic arterial system, that decreased arterial
compliance and increased characteristic impedance result in
widening pulse pressure (11–14).
In contrast, in PPH, the peripheral arteries are preferen-
tially involved and the resistance of peripheral arterial seg-
ments is increased without comparable changes in proximal
arterial resistance (10). The ratio of proximal resistance (char-
acteristic impedance) to peripheral resistance decreases in
PPH, which, in turn, increases mean arterial pressure without
comparable increases in pulse pressure.
Although the difference in pathologic findings seems to be
the major cause of the difference in pulsatility, because of the
retrospective study design, we could not rule out the possibility
that the larger degree of PR in the CPTE group might result in
larger pulsatility.
Pressure indexes derived from Doppler ultrasound mea-
surements. Doppler flow velocity measurements have often
been used for noninvasive measurements of cardiac chamber
pressure (15,16). This has been accomplished by making use of
the small regurgitation jet across the cardiac valves. Consider-
ing that patients with pulmonary hypertension usually have
both TR and PR, it is relatively easy to record these regurgitant
flow velocities in such patients. Strictly speaking, we can
estimate the pressure gradient across valves, but not the
absolute pressure values. The TR flow velocity provides the
systolic pressure gradient between the RV and the RA.
Because RA pressure is usually low, the peak pressure gradient
approximated the absolute peak PA pressure. The PR flow
velocity gives the diastolic pressure gradient between the PA
and the RV. Because RV pressure is low in diastole, the
pressure gradient at end-diastole is likely to reflect the abso-
lute value of PA diastolic pressure. Using invasive recordings
of mean RA pressure (6.1 6 1.9 [CPTE] and 9.5 6 2.6 [PPH]
mm Hg, p 5 0.01) and of RV end-diastolic pressure (9.1 6 3.4
[CPTE] and 11.3 6 3.9 [PPH] mm Hg, p 5 NS), pulsatility
indexes obtained after adding these pressure values (either
average or individual values) resulted in similar sensitivity
(0.95) and specificity (0.94) in differentiating CPTE from PPH.
To summarize, the use of pressure gradients across the tricus-
pid and pulmonary valves, as substitutes for absolute systolic
and diastolic pressures, respectively, seems reasonable for our
purpose. In our patient group, pulmonary diastolic pressure
itself estimated by Doppler ultrasound measurements could
separate CPTE and PPH reasonably well (sensitivity 0.89,
specificity 1); this might not hold, however, if patients with
more various systolic pressure values were included.
Study limitations. There are several limitations of this
study. First, the PPH group consisted of more women and
younger patients. The pulsatility indexes, however, were not
different between men and women and did not correlate with
age in either CPTE or PPH (data not shown). In addition, in
normal subjects, changes in pulsatility with age were relatively
small (17). These data indicate that age and gender did not
affect pulsatility indexes much. Furthermore, although CPTE
and PPH could be differentiated based on age and gender to
some degree (sensitivity 0.89, specificity 0.75), pulsatility in-
dexes provided much better differentiation between the two
groups.
Second, we retrospectively analyzed only a limited number
of patients. Performance of the indexes in differentiating
between CPTE and PPH depends on the patient group. To
generalize the results of this study, prospective studies involv-
ing many patients are essential, although accentuated pulsatil-
ity in CPTE and attenuated pulsatility in PPH seem to remain
useful, as the results reflect the unique mechanical character-
istics of PAs in patients with CPTE and PPH.
Many investigators have suggested that the pathophysiology
of CPTE and PPH may overlap to a certain extent (9,18). We
clinically diagnosed CPTE only when we could document
thrombi in the PA with arteriography, and PPH was diagnosed
by exclusion. Thus, PPH might include those patients with
minute thrombi undetectable by arteriography. Although the
clinical diagnosis generally relies on functional rather than
pure etiologic aspects of disease, the former is important as it
may indicate the possibility for surgical intervention (19).
Although both TR and PR flow velocities were not mea-
sured simultaneously, all patients were in sinus rhythm and the
pressure differences among beats were minor. Also, because
perfect alignment of the Doppler beam to the flow direction is
impossible, the measured flow velocity was minimally, but to
varying degrees, underestimated. Marked elevation of mean
RA pressure and RV end-diastolic pressures caused deviations
in absolute pressure values. Nevertheless, the fact that normal-
ized pulse pressure differentiated CPTE from PPH reasonably
well indicates that the pulse pressure indexes have significant
clinical values regardless of such errors in pressure estimation.
Conclusions. Doppler echocardiography may offer a new
approach to the differential diagnosis between patients with
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CPTE and those with PPH with moderate to severe pulmonary
hypertension.
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